Related by context. All words. (Click for frequent words.) 69 fosbretabulin 69 radiation sensitizer 69 vascular disrupting agents 68 proteasome inhibitor 67 GW# [003] 67 Voreloxin 67 thalidomide Thalomid 67 Xanafide 67 vascular disrupting agent 67 Seliciclib 66 cetuximab Erbitux ® 66 topically administered 66 Aflibercept 66 Pemetrexed 66 targeted radiotherapeutic 66 Tanespimycin 66 pan HDAC inhibitor 66 SYN# 66 sorafenib Nexavar 66 generation purine nucleoside 66 MAGE A3 ASCI 66 tigecycline 66 Zybrestat 66 indibulin 66 nucleoside analog 66 pertuzumab 65 mTOR inhibitor 65 phase IIb clinical 65 liposomal formulation 65 TG# [003] 65 Vidaza azacitidine 65 alpha 2a 65 IL# PE#QQR 65 receptor tyrosine kinase inhibitor 65 Cloretazine 65 Trastuzumab 65 Pathway Inhibitor 65 TBC# 65 vinca alkaloid 65 Traficet EN 65 metastatic malignant 65 ZYBRESTAT TM 65 Pegylated Liposomal Doxorubicin 65 etanercept Enbrel 65 VNP#M 65 orally administered inhibitor 65 Cannabinor 65 Tyrima 65 RhuDex ® 65 Proxinium TM 65 PEGylated interferon 65 angiogenesis inhibitor 65 Panzem R NCD 64 PDE4 inhibitor 64 CDK inhibitor 64 mitomycin 64 DOXIL 64 temsirolimus Torisel ® 64 PNP inhibitor 64 Cloretazine ® 64 bevacizumab Avastin ® 64 thymalfasin 64 antimetabolite 64 Cloretazine VNP#M 64 endothelin receptor antagonists 64 CEQ# 64 histone deacetylase HDAC inhibitor 64 Dacogen decitabine 64 Surgical resection 64 Temsirolimus 64 Ranibizumab 64 Bortezomib 64 Fenretinide 64 Amrubicin 64 luteinizing hormone releasing 64 BAY #-# 64 selective adenosine 64 CA4P 64 Carfilzomib 64 small molecule Hedgehog 64 EOquin 64 PrevOnco 64 cetuximab Erbitux R 64 echinocandin 64 Mipomersen 64 gemcitabine Gemzar 64 Pertuzumab 64 Deforolimus 64 Phase Ib study 64 Radezolid 64 idarubicin 64 chimeric monoclonal antibody 64 alkylating agent 64 PEP# ingenol mebutate Gel 64 Zarnestra 64 Fluorouracil 64 orally inhaled 64 Doxil ® 63 Panzem R 63 bortezomib Velcade R 63 XYOTAX TM 63 Specifid 63 targeted antifolate 63 selective antagonist 63 direct thrombin inhibitors 63 ALGRX 63 Aurora Kinase 63 Lenalidomide 63 docetaxel Taxotere ® 63 malignant ascites 63 BRAF inhibitor 63 SCCHN 63 ganetespib 63 histone deacetylase inhibitor 63 OncoVEX GM CSF 63 Chemokine Receptor 63 bortezomib Velcade 63 alefacept 63 CYT# potent vascular disrupting 63 Angiocept 63 ART# 63 HuMax EGFr 63 sunitinib malate 63 romidepsin 63 Enzastaurin 63 abatacept Orencia 63 2 methoxyestradiol 63 nanopharmaceutical 63 intranasal formulation 63 PEGylated Fab fragment 63 Degarelix 63 cisplatin gemcitabine 63 Omacetaxine 63 briakinumab 63 obatoclax 63 Cloretazine R 63 Diabetic Macular Edema DME 63 UPLYSO 63 liposomal amphotericin B 63 Melphalan 63 Onrigin 63 relapsed MM 63 depsipeptide 63 Dasatinib 63 Bevacizumab 63 cell lymphoma CTCL 63 Tarceva TM 63 compound AEZS 63 oral prodrug 63 FOLFOX6 63 radiotherapeutic 63 RhuDex TM 63 trastuzumab Herceptin 63 Onconase 63 octreotide acetate 63 Sudhir Agrawal D.Phil 63 CCX# 63 peripherally acting 63 CHOP chemotherapy 63 HQK 63 ATL# [001] 63 tanespimycin 63 Cloretazine R VNP#M 63 immunotherapeutic agent 63 PI3K/Akt pathway inhibitor 63 aflibercept VEGF Trap 63 Squalamine 63 gefitinib Iressa 62 lexidronam injection 62 dasatinib Sprycel ® 62 BAL# [002] 62 paclitaxel Taxol ® 62 Phase III randomized controlled 62 bevacizumab Avastin 62 ara C 62 systemic antifungal 62 refractory chronic lymphocytic 62 tumor xenograft models 62 galiximab 62 somatostatin analogue 62 non nucleoside inhibitor 62 oral ridaforolimus 62 mertansine 62 proteasome inhibitor bortezomib 62 5 fluorouracil leucovorin 62 beta 1a 62 investigational HCV polymerase 62 plus DOXIL 62 radiolabeled 62 mycophenolate mofetil 62 Clolar ® 62 ENMD # 62 antiangiogenic agent 62 Azedra TM 62 Zolinza 62 ZACTIMA 62 anticancer compound 62 leukemia AML 62 protein kinase inhibitor 62 Annamycin 62 Aplidin 62 Copegus ® 62 ofatumumab HuMax CD# 62 HepaSphere 62 RAV# 62 ribavirin Copegus ® 62 KB# [002] 62 YONDELIS 62 Phase #b/#a clinical 62 Panzem NCD 62 PSN# [002] 62 LHRH receptor positive 62 Bezielle 62 signal transduction inhibitor 62 HDACi 62 Archexin 62 topical antifungal 62 HSP# inhibitor 62 plasma kallikrein inhibitor 62 Exemestane 62 Irinotecan 62 Aplidin R 62 multitargeted 62 GSK# [001] 62 PEG IFN 62 Azedra 62 Estrogen Receptor 62 Taxol paclitaxel 62 Dapagliflozin 62 teriflunomide 62 TNF Tumor Necrosis Factor 62 reslizumab 62 Alocrest 62 rNAPc2 62 ATL# [002] 62 neoadjuvant treatment 62 HuMax CD4 62 Sphingomab 62 Perifosine 62 HDAC Inhibitor 62 INCB# [003] 62 EKC Cide 62 phase IIa clinical 62 platelet inhibitor 62 recurrent glioblastoma multiforme 62 Ambrisentan 62 Luteinizing Hormone Releasing Hormone 62 boosted protease inhibitor 62 Doxorubicin 62 SERMs 62 pegylated liposomal doxorubicin 62 Gemzar ® 62 Pegloticase 62 intravenous recombinant 62 abacavir Ziagen 62 chemotherapeutic drug 62 sodium glucose cotransporter 62 virus HCV protease inhibitor 62 Pyridorin 62 phase IIIb 62 unique alkylating agent 62 pain palliation 62 chemoradiotherapy 62 ixabepilone 62 Ozarelix 62 ribavirin RBV 62 pomalidomide 62 corticosteroid dexamethasone 62 WX UK1 62 cytostatic 61 huN# DM1 61 Tasigna nilotinib 61 Trabectedin 61 Aclidinium 61 humanised monoclonal antibody 61 Orally administered 61 Erlotinib 61 Alfacell proprietary ribonuclease 61 JAK2 inhibitor 61 EndoTAGTM 1 61 ZOLINZA 61 cilengitide 61 fallopian tube carcinoma 61 paclitaxel Taxol 61 Xelox 61 concurrent chemoradiation 61 neratinib 61 OvaRex ® MAb 61 PI3K inhibitors 61 elacytarabine 61 pharmacodynamic properties 61 AGHD 61 icatibant 61 Vandetanib 61 Epirubicin 61 gemcitabine Gemzar ® 61 PEG SN# 61 DUROS 61 Talabostat 61 demonstrated antitumor activity 61 posaconazole 61 Albuferon TM 61 resectable 61 Dalbavancin 61 Bafetinib 61 microtubule inhibitor 61 molecularly targeted 61 trial evaluating PRX# 61 Factor VIIa 61 MYCAMINE 61 zonisamide SR 61 MELAS 61 Nilotinib 61 taxane chemotherapy 61 Cytoxan ® 61 novel synthetic peptide 61 Romidepsin 61 haematologic 61 BRIM2 61 fluoropyrimidine 61 lapatinib Tykerb 61 IMA# 61 DFMO 61 Granisetron 61 monoclonal antibody conjugated 61 ongoing Phase 1b 61 OXi# 61 ELACYT 61 systemic anaplastic large 61 Sym# 61 gastrointestinal stromal tumors GIST 61 TELINTRA 61 florbetaben 61 Leukine ® 61 Paraplatin ® 61 Guanilib 61 Methylnaltrexone 61 liposomal doxorubicin 61 Elagolix 61 OMP #M# 61 docetaxel Taxotere 61 PEGINTRON TM 61 erlotinib Tarceva ® 61 Dacogen injection 61 Fulvestrant 61 Camptosar ® 61 Muraglitazar 61 EOquin TM 61 JAK inhibitor 61 Pegylated interferon 61 Saforis 61 KNS # 61 Pharmacokinetics PK 61 CYT# QbG# 61 irinotecan doxorubicin oxaliplatin paclitaxel 61 bleomycin 61 Pegasys ® 61 calcineurin inhibitors 61 Pegylated 61 Apoptone 61 PANVAC VF 61 Lubiprostone 61 Capecitabine 61 Safinamide 61 oral rivaroxaban 61 Aliskiren 61 pharmacokinetic interactions 61 prucalopride 61 vinorelbine tartrate 61 Personalized Immunotherapy 61 docetaxel Taxotere R 61 Epratuzumab 61 mRCC 61 Velcade bortezomib 61 Pixantrone 61 efalizumab 61 TYKERB 61 Azacitidine 61 Vidaza ® 61 nab paclitaxel 61 CBLC# 61 MEK inhibitors 61 investigational humanized monoclonal antibody 61 Alfimeprase 61 PARP inhibitor 61 GMX# 61 potent topoisomerase II 61 tyrosine kinase inhibitor 61 zalutumumab 61 antifolates 61 gemcitabine carboplatin 61 TEMODAL 61 imatinib Gleevec ® 61 preclinical efficacy 61 selective androgen receptor modulator 61 investigational monoclonal antibody 61 glycoprotein GP IIb IIIa 61 AEG# 61 gemcitabine cisplatin 61 Denufosol 61 IFN α 60 Cardiotoxicity 60 dextromethorphan quinidine 60 molecular chaperone regulator 60 SAR# [002] 60 Carbamazepine 60 orally bioavailable 60 BN# [004] 60 EGFR TKI 60 LHRH antagonist 60 vidofludimus 60 Gemcitabine 60 dexpramipexole 60 Ciclesonide 60 alvespimycin 60 Topotecan 60 capecitabine Xeloda 60 chemokine receptor 60 atypical hemolytic uremic syndrome 60 Vicinium TM 60 chemotherapeutic regimen 60 eluting stent 60 cutaneous T 60 Fludara ® 60 alfa 2a 60 Amplimexon 60 paclitaxel carboplatin 60 trabectedin 60 Teriflunomide 60 TKI therapy 60 systemically administered 60 octreotide implant 60 DCCR 60 Liposomal 60 Bosutinib 60 PRT# 60 cediranib 60 Glioblastoma Multiforme 60 tumor vascular disrupting 60 FASLODEX 60 potency selectivity 60 metaglidasen 60 Hycamtin ® 60 Silodosin 60 anti angiogenic agents 60 Virulizin ® 60 GEM OS2 60 Xeloda ® 60 delivers fluocinolone acetonide FA 60 elotuzumab 60 Tesetaxel 60 active moiety 60 CCR5 antagonist 60 invasive candidiasis 60 metastatic HRPC 60 oral proteasome inhibitor 60 selective estrogen receptor 60 Zenvia ™ 60 urothelial carcinoma 60 PEGylated interferon beta 1a 60 preclinically 60 MabCampath 60 Antiangiogenic 60 carboplatin paclitaxel 60 Sorafenib 60 Cell Lymphoma 60 biologic DMARD 60 phase IIb trial 60 PEGylated anti 60 Pafuramidine 60 azacytidine 60 orally dosed 60 docetaxel chemotherapy 60 IIb 60 Cetuximab Erbitux 60 Ecallantide 60 blinded randomized placebo controlled 60 ibritumomab tiuxetan 60 Phase 1b clinical trials 60 multicenter randomized placebo controlled 60 factor Xa 60 Apixaban 60 proteasome inhibitors 60 oral anti arrhythmic 60 benign prostatic hypertrophy BPH 60 Ranolazine 60 Clevudine 60 refractory AML 60 endothelin receptor 60 myelofibrosis polycythemia vera 60 Peginterferon alfa 2b 60 prostate carcinoma 60 herpetic keratitis 60 temsirolimus 60 lenalidomide dexamethasone 60 Loxapine 60 anti angiogenic agent 60 T#I [002] 60 Neoadjuvant 60 aspirin clopidogrel 60 immunomodulator 60 Gemzar gemcitabine 60 selective modulator 60 somatostatin analogues 60 sargramostim 60 visilizumab 60 long acting muscarinic 60 Acute Ischemic Stroke 60 rFVIIa 60 TriRima 60 multi kinase inhibitor 60 Cutaneous T 60 delafloxacin 60 biologic therapy 60 imatinib resistant 60 gastrointestinal stromal tumor 60 colorectal liver metastases 60 inhibitor RG# 60 NMIBC 60 Tocilizumab 60 HCV protease inhibitor 60 Sapacitabine 60 Diffuse Large B 60 trastuzumab Herceptin R 60 oncolytic vaccine 60 PSN# [001] 60 nucleoside reverse transcriptase inhibitor 60 Soft Tissue Sarcoma 60 RhuDex R 60 Zorbtive TM 60 superficial bladder cancer 60 Iloperidone 60 trastuzumab Herceptin ® 60 Taxol ® 60 doxorubicin HCl 60 Cytoxan 60 beta interferons 60 Afatinib 60 Tarvacin 60 MGd 60 ISF# 60 efficacy endpoint 60 ZD# [001] 60 samalizumab 60 IRX 2 60 LT NS# 60 Onco TCS 60 DLTs 60 metastatic CRC 60 FK# 60 lenalidomide Revlimid R 60 dasatinib Sprycel 60 sitaxsentan 60 temozolomide Temodar 60 Metastatic Melanoma 60 echinocandins 60 ceftazidime 60 Platinol ® 60 nucleoside 60 infusional 60 denileukin diftitox 60 mycosis fungoides 60 pimecrolimus 60 PEGASYS ® 60 Rituximab 60 follicular NHL 60 Mitoxantrone 60 sorafenib Nexavar ® 60 Peginterferon Alfa 2a 60 EDEMA3 60 novel topoisomerase 60 Kahalalide F 60 IMiD 60 Bevacizumab Avastin 60 EndoTAG TM -1 60 peritumoral brain edema 60 peptide conjugated 60 Daclizumab 60 novel histone deacetylase 60 5 HT3 antagonist 59 prochlorperazine 59 antiproliferative effects 59 vemurafenib 59 BENICAR HCT 59 generation Hsp# inhibitor 59 OvaRex MAb 59 palifosfamide 59 alendronate Fosamax 59 Targretin capsules 59 Darunavir 59 favorable pharmacokinetic profile 59 INC# 59 FOLPI 59 NXL# 59 CRLX# 59 alpha folate receptor 59 Myelodysplastic Syndrome MDS 59 Nitazoxanide 59 antiepileptics 59 Interferon alpha 59 DermaVir Patch 59 HGS# 59 Ophena TM 59 Delafloxacin 59 Ziprasidone 59 BIBW 59 BMS# 59 familial amyloidotic polyneuropathy FAP 59 highly selective endothelin 59 refractory prostate cancer 59 Fludarabine 59 Zoraxel TM 59 Vidofludimus 59 drug zotarolimus 59 CLORETAZINE TM VNP#M 59 immune modulating 59 antisense oligonucleotide 59 Receptor Antagonists 59 Telintra 59 TLR8 agonist 59 Neuradiab 59 highly selective inhibitor 59 Medidur ™ FA 59 STENT 59 intravenously administered 59 ALB # 59 REP# 59 anticancer agent 59 chemoradiation therapy 59 somatostatin analog 59 zotarolimus 59 including eniluracil ADH 59 IMC A# 59 amphotericin B 59 A2A receptor 59 CD3 monoclonal antibody 59 polymerase inhibitor 59 oral antiplatelet 59 metastatic renal cell carcinoma 59 formoterol fumarate 59 Ceflatonin 59 selective agonist 59 IMPDH inhibitor 59 PSMA ADC 59 phase IIb study 59 AVASTIN 59 Blinatumomab 59 prognostic biomarker 59 immunomodulatory therapy 59 tumor necrosis 59 ^ sup #m 59 oral nucleoside analogue 59 paclitaxel Taxol R 59 melphalan prednisone 59 Eltrombopag 59 neoadjuvant 59 injected subcutaneously 59 metaplasia 59 non squamous NSCLC 59 sorafenib tablets 59 Phase 2a Clinical Trial 59 antifibrotic 59 metastatic colorectal 59 AGGRASTAT R Injection tirofiban 59 intravesical instillation 59 patientswith 59 Pazopanib 59 novel prodrug 59 mineralocorticoid receptor 59 rilonacept 59 interferon IFN 59 bendamustine 59 Ophena 59 DAPT 59 Natalizumab 59 CLARITY study 59 Valdoxan 59 TELCYTA 59 ziconotide 59 chemotherapy hormonal therapy 59 Letairis ambrisentan 59 HeFH 59 relapsed refractory multiple myeloma 59 subcutaneously administered 59 GLPG# 59 Daptomycin 59 mimetics 59 gemtuzumab ozogamicin 59 persistent allergic conjunctivitis 59 PEG interferon 59 topical gel containing 59 Ceflatonin R 59 DACH platinum 59 Platinol 59 paclitaxel poliglumex 59 biliary tract cancer 59 sufentanil 59 fallopian tube cancers 59 administered subcutaneously 59 Inhaled nitric oxide 59 cangrelor 59 pegfilgrastim 59 noninfectious uveitis 59 Troxatyl 59 radezolid 59 Copegus ribavirin 59 DB# [003] 59 Gleevec resistant 59 Targretin 59 PRECISE 59 replicon 59 interferon alfa 2b 59 selective A1 adenosine 59 imatinib Gleevec 59 transdermal estradiol 59 conventional DMARDs 59 Imatinib mesylate 59 EGFR inhibitors 59 ritonavir boosted 59 5HT 59 Rindopepimut 59 IgG1 monoclonal antibody 59 XmAb# 59 Spiegelmer ® 59 Pradefovir 59 TNF alpha inhibitor 59 RE LY 59 nucleoside nucleotide 59 EZN 59 intralesional 59 alpha fetoprotein AFP 59 Elotuzumab 59 KSP inhibitor 59 recurrent GBM 59 TACE 59 PegIFN 59 rALLy clinical trial 59 Peginterferon 59 BMS # 59 bazedoxifene selective estrogen receptor 59 chemo immunotherapy 59 targeting CD# 59 Interferon beta 59 Combination therapy 59 NeoLipid R 59 Gleevec imatinib mesylate 59 Neovascular AMD 59 Glufosfamide 59 Akt activation 59 BrachySil 59 nanoviricide drug 59 Hedgehog Pathway Inhibitor 59 acute leukemias 59 nilotinib Tasigna ® 59 Advexin 59 Capesaris 59 nucleoside analogues 59 Crizotinib 59 Pharmacokinetic Study 59 oblimersen 59 Elvitegravir 59 peginterferon alpha 2a 59 irinotecan oxaliplatin 59 atypical Hemolytic Uremic Syndrome 59 Chronic Myeloid Leukemia CML 59 humanized monoclonal antibody 59 decitabine 59 regorafenib 59 kinase inhibition 59 glioblastoma multiforme GBM 59 Everolimus 59 Treanda 59 vinorelbine 59 basal cell carcinoma BCC 59 glatiramer acetate 59 Prospective Randomized 59 antiangiogenic therapy 59 NEUGENE 59 Helicobacter pylori eradication 59 erythropoietic 59 intravesical infusion therapy 59 topical gel formulation 59 Phase 2b Clinical Trial 59 IMiDs ® 59 Nexavar sorafenib 59 XL# XL# 58 selective A2A adenosine receptor 58 anti fibrotic 58 mesylate 58 selective inhibition 58 alemtuzumab Campath 58 metastatic hormone refractory 58 ESBA# 58 Lamotrigine 58 candesartan cilexetil 58 zotarolimus eluting stent 58 drug eluting stent DES 58 multicentre randomized 58 refractory cutaneous T 58 Yondelis ® 58 Etoposide 58 ISTODAX 58 ON #.Na 58 LEUKINE 58 FUSILEV enhances 58 Bruton tyrosine kinase Btk 58 glycopeptide 58 EGFR expressing 58 Multiple Myeloma MM 58 taxane resistant 58 omacetaxine mepesuccinate 58 IFN β 58 palliative radiotherapy 58 Glypromate 58 AMN# [001] 58 MEK inhibitor 58 Interferon beta 1a 58 IV NSCLC 58 Eraxis 58 prospective randomized multicenter 58 Abiraterone acetate 58 oxazolidinone 58 insulin sensitizers 58 epigenetic therapies 58 PD LID 58 PI3K inhibitor 58 fluvastatin 58 oral anticancer 58 FOLFIRI 58 enzastaurin 58 fulvestrant 58 Zemplar 58 bortezomib Velcade ® 58 iniparib 58 antiarrhythmic drug 58 5 FU leucovorin 58 CIMZIA TM 58 Symadex 58 Phase #/#a trial 58 veltuzumab 58 MALT lymphoma 58 verteporfin 58 Allovectin 7 ® 58 demethylating agent 58 NeoLipid TM 58 hematopoietic cancers 58 oral antiviral 58 papillary renal cell carcinoma 58 pheochromocytoma 58 factor Xa inhibitor 58 selective phosphodiesterase 58 inhibits protein synthesis 58 Randomized Phase 58 Angiotensin Converting Enzyme 58 Tacrolimus 58 non nucleoside 58 histological subtype 58 mesalazine 58 nonsmall cell lung cancer 58 peptide CGRP 58 angiotensin receptor blocker ARB 58 unfractionated heparin UFH 58 evaluating tivozanib 58 tricyclic antidepressants TCAs 58 Tasimelteon 58 polyglutamate 58 terlipressin 58 Pralatrexate 58 pegylated interferon alfa 2a 58 Navelbine ® 58 thetreatment 58 AAG geldanamycin analog 58 CG# [003] 58 Intravitreal 58 ibandronate 58 Hormone Refractory Prostate Cancer 58 agent VDA 58 trastuzumab emtansine T DM1 58 HMG CoA reductase inhibitors 58 inhaled corticosteroid ICS 58 Interferon alfa 58 Omacetaxine mepesuccinate 58 uric acid lowering 58 MGN# 58 Darinaparsin 58 DNA intercalator 58 myelofibrosis MF 58 Certolizumab pegol 58 2A receptor agonist 58 Peg IFN 58 novel VDA molecule 58 IV Busulfex 58 Decitabine 58 bullous 58 dihydrochloride 58 Imiquimod 58 CD# antibody [001] 58 nucleoside analogue 58 chemotherapy cisplatin 58 budesonide foam 58 calcipotriene 58 Allovectin 7 58 Faslodex 58 IAP inhibitor 58 Mycamine 58 Vincristine 58 carcinoid syndrome 58 OPAXIO 58 castration resistant prostate cancer 58 IIIb 58 benign neoplasms 58 erlotinib Tarceva 58 LY# [003] 58 estramustine 58 selective serotonin 2C receptor 58 trastuzumab DM1 T DM1 58 multicenter Phase II 58 nucleotide analogue 58 doxorubicin cyclophosphamide 58 protein mTOR 58 mecamylamine 58 Avanafil 58 Hepatocellular Carcinoma HCC 58 Plicera 58 Valopicitabine 58 rhIL 7 58 FOLFOX6 chemotherapy regimen 58 intravenous belinostat 58 DAVANAT 58 EGFR tyrosine kinase inhibitors 58 Boceprevir 58 mTOR inhibitors 58 polycythemia vera essential thrombocythemia 58 trans retinoic acid 58 TRC# 58 Eluting Coronary Stent System 58 antiplatelet agent 58 infusional 5-FU/LV 58 cisplatin chemotherapy 58 ALK inhibitor 58 Cytarabine 58 huC# DM4 58 resectable pancreatic cancer 58 dual orexin receptor 58 Acute Coronary Syndromes ACS 58 Alemtuzumab 58 p# mitogen activated 58 potent antiproliferative 58 TLR9 agonist 58 ISTODAX ® 58 CYC# 58 RezularTM 58 ORENCIA R 58 heparins 58 anti angiogenic therapy 58 gastrointestinal stromal tumor GIST 58 exendin 4 58 antithrombotics 58 potentially hepatotoxic 58 Teysuno 58 Interferon Alfa 58 cytotoxic chemotherapy 58 BEXXAR Therapeutic Regimen 58 xenograft models 58 HCQ 58 Hycamtin 58 epirubicin 58 hypereosinophilic syndrome 58 TAFA# 58 EndoTAG 58 busulfan 58 daptomycin 58 carmustine 58 atazanavir Reyataz 58 oxaliplatin Eloxatin 58 EmbraceAC 58 caspofungin 58 IFN beta 58 Sipuleucel T 58 T Pred 58 adriamycin 58 ACAPODENE 58 Eluting Stent 58 oral talactoferrin 58 Posaconazole 58 prospective multicenter 58 HCV replicon 58 antithrombotic 58 CLL SLL 58 mucinous 58 ZYBRESTAT fosbretabulin 58 pioglitazone HCl 58 TAXOTERE ® 58 assessing T DM1 58 metastatic bladder 58 Avastin bevacizumab 58 zoledronic acid Zometa 58 5 HT3 receptor 58 retapamulin